)
)
)
Washington Policy Briefing
As the policy environment in Washington continues to evolve, biotech leaders are seeking clarity on implications for R&D, investment, and patient access. This briefing will cover developments at FDA, CMS, and HHS and what stakeholders should expect next.
Speakers
.jpg)
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
